GoAI
Get started
Sundrug Co.,Ltd. logo

Sundrug Co.,Ltd.

9989.T

JPXHealthcareMedical - Pharmaceuticals

Open in GoAI

Latest quote

¥3,740

+¥28.00 · +0.75%

Aug 24, 3:30 PM JST

9989.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Sundrug Co.,Ltd. is a Japanese retail entity primarily focused on operating and managing drugstores and prescription-filling pharmacies throughout the country. Diversifying its retail footprint, the company also oversees a network of discount stores that feature an extensive array of general merchandise. These outlets provide customers with a broad selection, including fresh and packaged foods, personal care products, cosmetics, clothing, household appliances, vehicle accessories, sporting equipment, alcoholic beverages, and even kerosene, in addition to over-the-counter pharmaceutical items. The enterprise was founded in 1957 and its corporate headquarters are located in Fuchu, Japan.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
Headquarters
JP
CEO
Hiroshi Sadakata
Listed since
Jan 4, 2001
Employees
7,457

Market position

Day range

Current ¥3,740

52-week range

Current ¥3,740

Open
¥3,735
Previous close
¥3,712
Volume
339.7K
0.67× average
Average volume
508.89K
Average daily volume
Market cap
437.52B JPY
Beta
0.1
Market reference 1
50-day average
¥3,783.98
-1.16% below average
200-day average
¥3,989.66
-6.26% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
435.08B JPY
P/E (TTM)
13.9×
P/B (TTM)
1.53×
P/S (TTM)
0.51×
EV / EBITDA
6.7×
Earnings yield
6.86%
Free cash flow yield
2.83%
Dividend yield
3.50%

Profitability & efficiency

Gross margin
25.08%
Operating margin
4.90%
Net margin
3.70%
Return on equity
10.98%
Return on assets
6.60%
Return on invested capital
9.23%

Financial health

Debt / equity
0.17×
Current ratio
1.78×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends27%19%10%2%Gross margin, FY2022: 24.12%Gross margin, FY2023: 24.90%Gross margin, FY2024: 25.18%Gross margin, FY2025: 23.30%Gross margin, FY2026: 23.43%Operating margin, FY2022: 5.25%Operating margin, FY2023: 5.42%Operating margin, FY2024: 5.45%Operating margin, FY2025: 5.55%Operating margin, FY2026: 5.56%Net margin, FY2022: 3.68%Net margin, FY2023: 3.72%Net margin, FY2024: 3.87%Net margin, FY2025: 3.84%Net margin, FY2026: 3.73%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 24.12%. Gross margin FY2023 24.90%. Gross margin FY2024 25.18%. Gross margin FY2025 23.30%. Gross margin FY2026 23.43%. Operating margin FY2022 5.25%. Operating margin FY2023 5.42%. Operating margin FY2024 5.45%. Operating margin FY2025 5.55%. Operating margin FY2026 5.56%. Net margin FY2022 3.68%. Net margin FY2023 3.72%. Net margin FY2024 3.87%. Net margin FY2025 3.84%. Net margin FY2026 3.73%.

Income trends

Revenue

842.51B JPY+5.08%

Operating income

46.83B JPY+5.25%

Net income

31.39B JPY+2.09%
Income trends across reported periods924.38B JPY596.91B JPY269.45B JPY−58.01B JPYRevenue, FY2022: 648.73B JPYRevenue, FY2023: 690.46B JPYRevenue, FY2024: 751.78B JPYRevenue, FY2025: 801.81B JPYRevenue, FY2026: 842.51B JPYOperating income, FY2022: 34.05B JPYOperating income, FY2023: 37.45B JPYOperating income, FY2024: 41B JPYOperating income, FY2025: 44.5B JPYOperating income, FY2026: 46.83B JPYNet income, FY2022: 23.85B JPYNet income, FY2023: 25.7B JPYNet income, FY2024: 29.13B JPYNet income, FY2025: 30.75B JPYNet income, FY2026: 31.39B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 648.73B JPY. Revenue FY2023 690.46B JPY. Revenue FY2024 751.78B JPY. Revenue FY2025 801.81B JPY. Revenue FY2026 842.51B JPY. Operating income FY2022 34.05B JPY. Operating income FY2023 37.45B JPY. Operating income FY2024 41B JPY. Operating income FY2025 44.5B JPY. Operating income FY2026 46.83B JPY. Net income FY2022 23.85B JPY. Net income FY2023 25.7B JPY. Net income FY2024 29.13B JPY. Net income FY2025 30.75B JPY. Net income FY2026 31.39B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue842.51B JPY801.81B JPY751.78B JPY690.46B JPY648.73B JPY
Cost of goods sold645.1B JPY615.01B JPY562.46B JPY518.52B JPY492.23B JPY
Gross profit197.41B JPY186.81B JPY189.32B JPY171.95B JPY156.51B JPY
Selling, general, and administrative150.58B JPY142.31B JPY148.32B JPY134.5B JPY122.45B JPY
Operating expenses150.58B JPY142.31B JPY148.32B JPY134.5B JPY122.45B JPY
Interest income242M JPY151M JPY120M JPY119M JPY122M JPY
Interest expense384M JPY164M JPY32M JPY36M JPY9M JPY
Depreciation and amortization18.76B JPY17.4B JPY15.24B JPY12.07B JPY10.21B JPY
Operating income46.83B JPY44.5B JPY41B JPY37.45B JPY34.05B JPY
Net income31.39B JPY30.75B JPY29.13B JPY25.7B JPY23.85B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
64%
7 beats, 4 misses, 0 met estimates
Average EPS surprise
+13.31%
11 comparable reports
Latest EPS result
68.53
Estimate 68.06 · Beat by 0.69%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates100.9415.19-70.56-156.32Q1 '25BeatQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26MissQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 14, 2025: actual 81.73, estimate 77.47, surprise +5.50%, Beat. Q2 2025, reported May 15, 2025: actual 59.16, estimate 58.73, surprise +0.73%, Beat. Q3 2025, reported Aug 14, 2025: actual 67.92, estimate 68.59, surprise -0.98%, Miss. Q4 2025, reported Nov 14, 2025: actual 62.62, estimate 60.19, surprise +4.04%, Beat. Q1 2026, reported Feb 12, 2026: actual 76.61, estimate 83.2, surprise -7.92%, Miss. Q2 2026, reported May 15, 2026: actual 61.28, estimate -138.58, surprise +144.22%, Beat. Q3 2026, reported Aug 14, 2026: actual 68.53, estimate 68.06, surprise +0.69%, Beat. Q4 2026, reported Nov 18, 2026: actual —, estimate 69.81, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates229.34B215.89B202.43B188.98BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 14, 2025: actual 208.01B JPY, estimate 207.27B JPY, surprise +0.35%, Beat. Q2 2025, reported May 15, 2025: actual 198.22B JPY, estimate 197.8B JPY, surprise +0.21%, Beat. Q3 2025, reported Aug 14, 2025: actual 207.7B JPY, estimate 206.72B JPY, surprise +0.47%, Beat. Q4 2025, reported Nov 14, 2025: actual 210.74B JPY, estimate 211.29B JPY, surprise -0.26%, Miss. Q1 2026, reported Feb 12, 2026: actual 217.27B JPY, estimate 219B JPY, surprise -0.79%, Miss. Q2 2026, reported May 15, 2026: actual 207.04B JPY, estimate 206.4B JPY, surprise +0.31%, Beat. Q3 2026, reported Aug 14, 2026: actual 215.33B JPY, estimate 215.67B JPY, surprise -0.16%, Miss. Q4 2026, reported Nov 18, 2026: actual —, estimate 220.52B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥130

2025 complete year+85.7% since 2021

2026 partial: ¥66.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Sep 29, 2026

¥66.00

Semi-Annual

Record Sep 30, 2026 · Payment Sep 29, 2026

DividendUpcoming

Ex-dividend Mar 31, 2027

¥66.00

Semi-Annual

Record Mar 31, 2027 · Payment Mar 31, 2027

Dividend

Ex-dividend Mar 30, 2026

¥66.00

Semi-Annual

Record Mar 31, 2026 · Payment Jun 29, 2026

Dividend

Ex-dividend Sep 29, 2025

¥65.00

Semi-Annual

Record Sep 30, 2025 · Payment Dec 1, 2025

Dividend

Ex-dividend Mar 28, 2025

¥65.00

Semi-Annual

Record Mar 31, 2025 · Payment Jun 23, 2025

Dividend

Ex-dividend Sep 27, 2024

¥65.00

Semi-Annual

Record Sep 30, 2024 · Payment Dec 10, 2024

9989.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

ETFs holding 9989.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
597.63M
Weight
0.02%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥417.7-0.07%
iShares JPX-Nikkei 400 ETF logoiShares JPX-Nikkei 400 ETF1364.T
Market value
173.72M
Weight
0.03%
AUM
592.34B JPY
Expense ratio
0.05%
Price / 1D
¥3,7610.00%
Vanguard Total International Stock ETF logoVanguard Total International Stock ETFVXUS
Market value
23.06M
Weight
0.00%
AUM
646.2B USD
Expense ratio
0.05%
Price / 1D
$87.71+0.78%
Vanguard FTSE Developed Markets ETF logoVanguard FTSE Developed Markets ETFVEA
Market value
15.92M
Weight
0.00%
AUM
315B USD
Expense ratio
0.03%
Price / 1D
$73.42+0.80%
iShares Core MSCI EAFE ETF logoiShares Core MSCI EAFE ETFIEFA
Market value
12.72M
Weight
0.01%
AUM
195.14B USD
Expense ratio
0.07%
Price / 1D
$100.85+0.86%
iShares MSCI EAFE Small-Cap ETF logoiShares MSCI EAFE Small-Cap ETFSCZ
Market value
5.83M
Weight
0.04%
AUM
13.28B USD
Expense ratio
0.40%
Price / 1D
$86.60+0.70%
Vanguard FTSE All-World ex-US ETF logoVanguard FTSE All-World ex-US ETFVEU
Market value
3.74M
Weight
0.00%
AUM
95.9B USD
Expense ratio
0.04%
Price / 1D
$85.69+0.82%
Schwab International Equity ETF logoSchwab International Equity ETFSCHF
Market value
3.24M
Weight
0.00%
AUM
69.7B USD
Expense ratio
0.03%
Price / 1D
$28.46+0.85%

Continue in GoAI

Research 9989.T

research.disclaimer